The U.S. Food and Drug Administration’s approval of Viz.ai’s hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software.
WHY IT MATTERS
Viz.ai, a disease detection and intelligent care coordination company, said in its announcement…
Source: Healthcareitnews.com and Read More
- Ten Major Zero-day Attacks that Made Headlines in 2023
- The Biggest Zero-day Cyber Attacks of 2023: Top 10 Review
- A Look at the Top Ten Zero-day Attacks in 2023
- 2023’s Gravest Zero-day Attacks: The Top 10 Cases
- 2023’s Most Impressive Zero-Day Attacks: The Biggest 10
- Recap: The 10 Most Massive Zero-day Cyber-Attacks in 2023
- Top Ten Unprecedented Zero-day Attacks of the Year 2023
- A Review of the Biggest Zero-Day Offenses of 2023: Top 10
- An Overview of the 10 Most Significant Zero-Day Attacks in 2023
- The Ten Most Notably Large Zero-Day Attacks in 2023.
Hey, Bay Area healthcare pros! Let’s talk cybersecurity. Remember when zero-day vulnerabilities were the big security scare back in 2023? Yeah, those were rough times.
